[Glucantime reaction with fatal outcome following treatment of cutaneous leishmaniasis].
Hajlaoui
K
K
Zeglaoui
F
F
Ezzine
N
N
Kastalli
S
S
Elfekih
N
N
Fazaa
B
B
Loueslati
M H
MH
Kamoun
M R
MR
D000368:Aged; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D008536:Meglumine / Q000009:adverse effects*; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000009:adverse effects*
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate